Discover
REVB
Revelation Biosciences, Inc.
1.04
2 x 0.76
2 x 1.34
bid
ask
+
0.01
0.97%
2 @ 04:00 PM
1.05 +0.01 (0.96%)
| Ytd | -67.50% | |
| 1y | -89.43% |
1.02
day range
1.06
0.88
52 week range
12.88
| Open | 1.02 | Prev Close | 1.03 | Low | 1.02 | High | 1.06 | Mkt Cap | 4.06M |
| Vol | 25.16K | Avg Vol | 61.20K | EPS | -1.32 | P/E | N/A | Forward P/E | -0.13 |
| Beta | 0.15 | Short Ratio | 0.11 | Inst. Own | 8.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.05 | 200-d Avg | 2.69 | 1yr Est | 12.75 |
| Income Statement | |||
| Operating Expenses | 3.09M | ||
| Research and Development Expense | 1.38M | ||
| Selling, General and Administrative Expense | 1.72M | ||
| Operating Income | -3.09M | ||
| Net Income | -3.01M | ||
| Net Income Common Stock | -8.69M | ||
| Net Income Common Stock (USD) | -8.69M | ||
| Consolidated Income | -3.01M | ||
| Earnings per Basic Share | -2.71 | ||
| Earnings per Basic Share (USD) | -2.71 | ||
| Earnings per Diluted Share | -2.71 | ||
| Earning Before Interest & Taxes (EBIT) | -3.01M | ||
| Earning Before Interest & Taxes (USD) | -3.01M | ||
| Preferred Dividends Income Statement Impact | 5.68M | ||
| Weighted Average Shares | 3.21M | ||
| Weighted Average Shares Diluted | 3.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.11M | ||
| Cash and Equivalents (USD) | 14.11M | ||
| Current Assets | 14.21M | ||
| Property, Plant & Equipment Net | 807.31K | ||
| Total Assets | 15.04M | ||
| Debt Current | 120.86K | ||
| Total Debt | 759.04K | ||
| Current Liabilities | 1.42M | ||
| Debt Non-Current | 638.18K | ||
| Total Liabilities | 2.06M | ||
| Accumulated Retained Earnings (Deficit) | -52.43M | ||
| Shareholders Equity | 12.99M | ||
| Shareholders Equity (USD) | 12.99M | ||
| Assets Non-Current | 838.25K | ||
| Total Debt (USD) | 759.04K | ||
| Liabilities Non-Current | 638.18K | ||
| Trade and Non-Trade Payables | 828.20K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 62.90K | ||
| Net Cash Flow from Financing | 6.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.41M | ||
| Capital Expenditure | -71.88K | ||
| Net Cash Flow from Investing | -71.88K | ||
| Net Cash Flow from Operations | -3.21M | ||
| Share Based Compensation | 471.00K | ||